1. Effect of ligands that increase cAMP on caerulein-induced zymogen activation in pancreatic acini
- Author
-
Lu, Z., Kolodecik, T.R., Karne, S., Nyce, M., and Gorelick, F.
- Subjects
Chymotrypsin -- Research ,Biological sciences - Abstract
Lu, Z., T. R. Kolodecik, S. Karne, M. Nyce, and F. Gorelick. Effect of ligands that increase cAMP on caeruleininduced zymogen activation in pancreatic acini. Am J Physiol Gastrointest Liver Physiol 285: G822-G828, 2003. First published July 24, 2003; 10.1152/ajpgi.00213.2003.--The pathological activation of proteases within the pancreatic acinar cell is critical to initiating pancreatitis. Stimulation of acinar cells with supraphysiological concentrations of the CCK analog caerulein (CER) leads to protease activation and pancreatitis. Agents that sensitize the acinar cell to the effects of CCK might contribute to disease. The effects of physiological ligands that increase acinar cell cAMP [secretin, VIP, and pituitary adenylate cyclase activating peptide (PACAP)] on CER-induced responses were examined in isolated rat pancreatic acini. Each ligand sensitized the acinar cell to zymogen activation by physiological concentrations of CER (0.1 nM). VIP and PACAP but not secretin also enhanced activation by supraphysiological concentrations of CER (0.1 [micro]M). A cell-permeable cAMP analog also sensitized the acinar cell to CER-induced activation. The cAMP antagonist Rp-8-BrcAMP inhibited these sensitizing effects. These findings suggest that ligands that increase acinar cell cAMP levels can sensitize the acinar cell to the effects of CCK-induced zymogen activation. caerulein; chymotrypsin; secretin; trypsin
- Published
- 2003